Journal List > J Korean Ophthalmol Soc > v.60(6) > 1127184

Lee and Shin: Clinical Study of Changes in Eye Dominance after Pseudophakic Conventional Monovision

Abstract

Purpose

The purpose of this study was to evaluate whether eye dominance changes after conventional pseudophakic monovision, and to identify factors that affect changes in eye dominance.

Methods

This retrospective study included 70 patients who underwent bilateral conventional monovision cataract surgery. Patients were divided into two groups based on whether they experienced a change in the dominant eye. We compared patients' uncorrected distance visual acuity (UCDVA), uncorrected near visual acuity (UCNVA), best-corrected visual acuity (BCVA), spherical equivalent, stereopsis, and time interval between cataract surgeries.

Results

The mean age was 71.26 ± 10.84 (range, 25–90) years, mean interval between surgery in each eye was 118.46 ±183.50 (range, 17–1,018) days, and mean postoperative diopter difference was 1.16 ± 0.53 (range, 0.00–2.75) diopters. After bilateral cataract surgery, 22 patients (31.43%) experienced a change in eye dominance, whereas 48 patients (68.57%) experienced no change. There were no differences in the time interval between cataract surgeries, preoperative UCDVA and UCNVA, pre- and postoperative BCVA, or stereopsis in either group. Patients who experienced a change in eye dominance showed smaller differences between preoperative and postoperative spherical equivalent, compared with patients who experienced no change in eye dominance (t-test, p < 0.05).

Conclusions

Twenty-two (31.43%) patients whose nondominant eyes were targeted for near vision showed altered eye dominance after conventional monovision cataract surgery. Eye dominance shows greater plasticity in patients with smaller differences between preoperative and postoperative spherical equivalent.

References

1. Greenstein S, Pineda R 2nd. The quest for spectacle independence: a comparison of multifocal intraocular lens implants and abdominal monovision for patients with presbyopia. Semin Ophthalmol. 2017; 32:111–5.
2. Iida Y, Shimizu K, Ito M. Pseudophakic monovision using abdominal and multifocal intraocular lenses: hybrid monovision. J Cataract Refract Surg. 2011; 37:2001–5.
3. Yoo R, Shin KC. Clinical results of pseudophakic monovision 1 year after cataract surgery. J Korean Ophthalmol Soc. 2016; 57:1882–90.
crossref
4. Zhang F, Sugar A, Jacobsen G, Collins M. Visual function and abdominal satisfaction: comparison between bilateral diffractive abdominal intraocular lenses and monovision pseudophakia. J Cataract Refract Surg. 2011; 37:446–53.
5. Zhang F, Sugar A, Arbisser L, et al. Crossed versus conventional pseudophakic monovision: patient satisfaction, visual function, and spectacle independence. J Cataract Refract Surg. 2015; 41:1845–54.
crossref
6. Schwartz R, Yatziv Y. The effect of cataract surgery on ocular dominance. Clin Ophthalmol. 2015; 9:2329–33.
crossref
7. Zoccolotti P. Inheritance of ocular dominance. Behav Genet. 1978; 8:377–9.
crossref
8. Reiss MR. Ocular dominance: some family data. Laterality. 1997; 2:7–16.
crossref
9. Jiang F, Chen Z, Bi H, et al. Association between ocular sensory dominance and refractive error asymmetry. PLoS One. 2015; 10:e0136222.
crossref
10. Terasaki H, Yamashita T, Yoshihara N, et al. Association of abdominal and body structure to ocular axial length in Japanese abdominal school children. BMC Ophthalmol. 2017; 17:123.
crossref
11. Balog J, Matthies U, Naumann L, et al. Social experience abdominal ocular dominance plasticity differentially in adult male and female mice. Neuroimage. 2014; 103:454–61.
12. Boerner CF, Thrasher BH. Results of monovision correction in abdominal pseudophakes. J Am Intraocul Implant Soc. 1984; 10:49–50.
13. Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. Cataract. 3rd ed.Seoul: ILCHOKAK Publishing Co., Ltd.;2014. p. 499.
14. Chakrabarti A. Cataract surguery in diseased eyes. 1st ed.New Delhi: Jaypee Brothers Medical Pub;2014. p. 53. 219–20.
15. Misae Ito CO, Shimizu K. Monovision strategies: our experience and approach on pseudophakic monovision. Clin Surg. 2018; 3:2027.
16. Kohnen T, Koch DD. Cataract and refractive surgery. Berlin: Springer Science & Business Media;2006. p. 139.
17. Charness N, Dijkstra K, Jastrzembski T, et al. Monitor viewing abdominal for younger and older workers. Proceedings of the Human Factors and Ergonomics Society Annual Meeting. 2008; 52:1614–7.
18. Jain S, Ou R, Azar DT. Monovision outcomes in presbyopic abdominal after refractive surgery. Ophthalmology. 2001; 108:1430–3.
19. Kim J, Shin HJ, Kim HC, Shin KC. Comparison of conventional versus crossed monovision in pseudophakia. Br J Ophthalmol. 2015; 99:391–5.
crossref
20. Pepin SM. Neuroadaptation of presbyopia-correcting intraocular lenses. Curr Opin Ophthalmol. 2008; 19:10–2.
crossref
21. Kim YJ, Cheon MH, Ko DA, et al. Visual function and patient abdominal in pseudophakic monovision. J Korean Ophthalmol Soc. 2012; 53:1621–9.
22. Seijas O, Gómez de Liaño P, Gómez de Liaño R, et al. Ocular abdominal diagnosis and its influence in monovision. Am J Ophthalmol. 2007; 144:209–16.
23. Handa T, Mukuno K, Uozato H, et al. Ocular dominance and abdominal satisfaction after monovision induced by intraocular lens implantation. J Cataract Refract Surg. 2004; 30:769–74.
24. Collins M, Goode A, Brown B. Distance visual acuity and monovision. Optom Vis Sci. 1993; 70:723–8.
crossref
25. Chen M. Accommodation in pseudophakic eyes. Taiwan J Ophthalmol. 2012; 2:117–21.
crossref
26. Kommerell G, Schmitt C, Kromeier M, Bach M. Ocular prevalence versus ocular dominance. Vision Res. 2003; 43:1397–403.
crossref
27. Ooi TL, He ZJ. Sensory eye dominance. Optometry. 2001; 72:168–78.
28. Heimel JA, van Versendaal D, Levelt CN. The role of GABAergic inhibition in ocular dominance plasticity. Neural Plast. 2011; 2011:391763.
crossref
29. Adams DL, Sincich LC, Horton JC. Complete pattern of ocular dominance columns in human primary visual cortex. J Neurosci. 2007; 27:10391–403.
crossref
30. Coleman JE, Law K, Bear MF. Anatomical origins of ocular abdominal in mouse primary visual cortex. Neuroscience. 2009; 161:561–71.
31. Adams DL, Horton JC. Ocular dominance columns in strabismus. Vis Neurosci. 2006; 23:795–805.
crossref

Figure 1.
Comparison of Preoperative spherical equivalent difference of both eyes (the magnitude of anisometropia) between changed eye dominance group and unchanged eye dominance group. There are significant differences between the two groups (p = 0.01, t-test).
jkos-60-534f1.tif
Table 1.
Baseline characteristics of patients
  Changed eye dominance group Unchanged eye dominance group p-value
Patients 22 (31.4) 48 (68.6)  
Age (years) 70.5 ± 11.3 71.6 ± 10.7 0.70*
Gender
 Male 2 (9.1) 13 (35.1) 0.12
 Female 20 (90.9) 35 (72.9)  
Dominant eye
 Right 11 (50.0) 26 (54.2)  
 Left 11 (50.0) 22 (45.8)  

Data are expressed as mean ± standard deviation or number (%).

* Mann-Whitney U test

Fisher's exact test.

Table 2.
Comparison of spherical equivalent between changed group and unchanged group
  Changed eye dominance group Unchanged eye dominance group p-value*
Number of eyes 22 (31.4) 48 (68.6)  
Time interval between cataract surgeries 109.50 ± 125.77 122.56 ± 205.70 0.78
Preoperative spherical equivalent of the dominant eye 0.13 ± 1.29 −0.74 ± 2.45 0.20
Preoperative spherical equivalent of nondominant eye Preoperative spherical equivalent difference 0.09 ± 1.35 0.39 ± 0.31 −0.68 ± 2.87 0.84 ± 1.07 0.30 0.01
Postoperative spherical equivalent of the dominant eye −1.26 ± 0.51 −0.16 ± 0.57 <0.01
Postoperative spherical equivalent of nondominant eye −0.11 ± 0.38 −1.23 ± 0.67 <0.01
Postoperative spherical equivalent difference 1.15 ± 0.40 1.17 ± 0.59 0.87

Values are expressed as mean ± standard deviation or number (%).

* Mann-Whitney U test

t-test.

Table 3.
Comparison of visual acuity between changed group and unchanged group
  Changed eye dominance group Unchanged eye dominance group p-value*
Preoperative UCDVA (logMAR)      
 Dominant eye 0.30 ± 0.24 0.35 ± 0.25 0.30
 Non-dominant eye 0.31 ± 0.28 0.36 ± 0.27 0.40
Preoperative UCNVA (logMAR)      
 Dominant eye 0.48 ± 0.22 0.66 ± 0.39 0.08
 Non-dominant eye 0.47 ± 0.26 0.64 ± 0.39 0.16
Preoperative BCVA (logMAR)      
 Dominant eye 0.25 ± 0.18 0.31 ± 0.24 0.50
 Non-dominant eye 0.17 ± 0.13 0.23 ± 0.24 0.72
Postoperative UCDVA (logMAR)      
 Dominant eye 0.20 ± 0.16 0.10 ± 0.15 <0.01
 Non-dominant eye 0.07 ± 0.11 0.19 ± 0.16 <0.01
Postoperative UCNVA (logMAR)      
 Dominant eye 0.20 ± 0.11 0.52 ± 0.34 <0.01
 Non-dominant eye 0.46 ± 0.27 0.29 ± 0.25 <0.01
Postoperative BCVA (logMAR)      
 Dominant eye 0.03 ± 0.05 0.04 ± 0.05 0.95
 Non-dominant eye 0.02 ± 0.03 0.04 ± 0.06 0.12

Values are expressed as mean ± standard deviation unless otherwise indicated.

UCDVA = uncorrected distant visual acuity; logMAR = logarithm of the minimum angle of resolution; UCNVA = uncorrected near visual acuity; BCVA = best corrected visual acuity.

* Mann-Whitney U test.

Table 4.
Comparison of stereopsis between changed group and unchanged group
  Changed eye dominance group Unchanged eye dominance group p-value*
Preoperative stereopsis 234.50 ± 216.13 229.21 ± 230.28 0.46
Postoperative stereopsis 248.00 ± 265.42 250.43 ± 256.64 0.80

Values are expressed as seconds of arc. Values are expressed as mean ± standard deviation unless otherwise indicated.

* Mann-Whitney U test.

TOOLS
Similar articles